Before starting any protocol, a conversation with a licensed provider will always serve you better than a dosage chart found online
Epithalon (sometimes spelled Epitalon) is a four-amino-acid synthetic peptide developed by Professor Vladimir Khavinson at the St
Because it modulates cellular NAD+ availability and mitochondrial function, some protocols administer it in the morning to align peak NNMT inhibition with waking metabolic activity
Ask any orthopedic surgeon what makes tendons and ligaments so frustrating to treat, and you'll get some version of the same answer: they barely have a blood supply
Patients who already qualify for GLP-1 therapy and would like additional support Individuals with suboptimal B12 levels or risk of deficiency Those who prefer combining metabolic and micronutrient therapy Patients fully committed to close medical oversight and follow-up However, its not recommended if you have contraindications to GLP-1 agents, are pregnant, breastfeeding, have uncontrolled GI disease, or cannot adhere to monitoring and follow-up